NCT02136134 Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT02135874 Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia Status COMPLETED Phase PHASE2
NCT02121262 A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT02119468 Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02114502 Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma Status WITHDRAWN Phase PHASE2
NCT02112916 Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02111785 Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma Status TERMINATED Phase PHASE2/PHASE3
NCT02109861 Microdose Study of Melphalan, Bortezomib and Dexamethasone Status UNKNOWN Phase EARLY_PHASE1
NCT02106988 Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02106494 A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC Status COMPLETED Phase PHASE3
NCT02104778 Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine Status UNKNOWN Phase NA
NCT02102815 Efficacy of Preoperative Intravenous Dexamethasone in Primary Total Knee Arthroplasty Status COMPLETED Phase PHASE4
NCT02101944 Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02101853 Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02100657 Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02096835 Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting Status COMPLETED Phase NA
NCT02095834 Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1